Title |
Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial
|
---|---|
Published in |
European Journal of Clinical Pharmacology, September 1993
|
DOI | 10.1007/bf00315501 |
Pubmed ID | |
Authors |
B. Montes, M. Catalan, A. Roces, J. P. Jeanniot, J. M. Honorato |
Abstract |
The absolute bioavailability of fenspiride has been studied in twelve healthy volunteers. It was administered IV and orally in single doses of 80 mg fenspiride hydrochloride according to a randomised crossover pattern. Following IV administration, the plasma clearance of fenspiride was about 184 ml.min-1, and its apparent volume of distribution was moderately large (215 l). When given orally as a tablet, fenspiride exhibited fairly slow ab- sorption; the maximum plasma concentration (206 ng.ml-1) was achieved 6 h after administration. The absolute bioavailability was almost complete (90%). The tablet had slow release characteristics. The elimination half-life obtained from the plasma data was 14 to 16 h independent of the route of administration. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 17% |
Unknown | 5 | 83% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 50% |
Professor > Associate Professor | 1 | 17% |
Other | 1 | 17% |
Student > Master | 1 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 50% |
Medicine and Dentistry | 3 | 50% |